Trials in EGFR Mutated NSCLC: Flaura2 and Mariposa- 2024 Leading Developments in Lung Cancer

Drs. Desai and Abu Rous discuss emerging information and trial data as presented at ASCO 2024. In this video, Drs. Desai and Abu Rous discuss the trial date from Flaura2 and Mariposa as presented at 2024 ASCO, and the implications in treating EGFR+ NSCLC. View English Transcript here: https://drive.google.com/file/d/13wd4... View Spanish Transcript here: https://drive.google.com/file/d/1FoHW... View Mandarin Transcript here: https://drive.google.com/file/d/1sV3C... Thank You to our Sponsors: #bms #lilly #summit #takeda #janssen For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum. Music: Photo Album (BenSound) License: YRPCQ9INEFDTTPT8